EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cerebral venous thrombosis in patients with autoimmune disease, hematonosis or coronavirus disease 2019: Many familiar faces and some strangers

Yifan Zhou, Huimin Jiang, Huimin Wei, Xuechun Xiao, Lu Liu, Xunming Ji iD, Chen Zhou

CNS Neuroscience & Therapeutics · 2023

DOI: 10.1111/cns.14321 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift CNS Neuroscience & Therapeutics, 2023. Verfasst von Yifan Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Brain Disorders, Ministry of Science and Technology, Collaborative Innovation Center for Brain Disorders, Beijing Institute of Brain Di…. Hauptthemen laut MEDLINE: COVID-19, Stroke, Intracranial Thrombosis, Venous Thrombosis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 223 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cerebral venous thrombosis, a rare stroke, is characterized by neurological dysfunction caused by bleeding and/or infarction resulting from venous sinus thrombosis, the so‐called venous stroke. Current guidelines recommend anticoagulants as first‐line therapy in the treatment of venous stroke. With complicated causes of cerebral venous thrombosis, treatment is difficult, especially when combined with autoimmune diseases, blood diseases, and even COVID‐19.

Aims

This review summarizes the pathophysiological mechanisms, epidemiology, diagnosis, treatment, and clinical prognosis of cerebral venous thrombosis combined with autoimmune diseases, blood diseases, or infectious diseases such as COVID‐19.

Conclusion

A systematic understanding of particular risk factors that should not be neglected when unconventional cerebral venous thrombosis occurs and for a scientific understanding of pathophysiological mechanisms, clinical diagnosis, and treatment, thus contributing to knowledge on special types of venous stroke.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19StrokeIntracranial ThrombosisVenous ThrombosisAutoimmune DiseasesSinus Thrombosis, IntracranialHumansAnticoagulants

Stichwörter der Autor:innen

COVID-19autoimmune diseasesblood diseasesstrokevector-based vaccinevenous stroke

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Laboratory of Brain Disorders, Ministry of Science and Technology, Collaborative Innovation Center for Brain Disorders, Beijing Institute of Brain Disorders, Beijing Advanced Innovation Center for Big Data-based Precisi…
  • Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, School of Engineering Medicine, Beihang University, Beijing, China.
  • Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
  • Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China.

ORCID-Profile: Xunming Ji

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhou, Y., Jiang, H., Wei, H., Xiao, X., Liu, L., Ji, X., & Zhou, C. (2023). Cerebral venous thrombosis in patients with autoimmune disease, hematonosis or coronavirus disease 2019: Many familiar faces and some strangers. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.14321

Vancouver

Zhou Y, Jiang H, Wei H, Xiao X, Liu L, Ji X, et al. Cerebral venous thrombosis in patients with autoimmune disease, hematonosis or coronavirus disease 2019: Many familiar faces and some strangers. CNS Neuroscience & Therapeutics. 2023. doi:10.1111/cns.14321

BibTeX
@article{Zhou2023,
  author = {Zhou, Yifan and Jiang, Huimin and Wei, Huimin and Xiao, Xuechun and Liu, Lu and Ji, Xunming and Zhou, Chen},
  title = {Cerebral venous thrombosis in patients with autoimmune disease, hematonosis or coronavirus disease 2019: Many familiar faces and some strangers},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2023},
  doi = {10.1111/cns.14321}
}
Kostenlos starten →